ClinicalTrials.gg
Active, not recruitingNCT07479069Updated Mar 18, 2026

Erector Spinae Plane Block for Pain Control After Open Abdominal Surgery

An interventional study of Bilateral Erector Spinae Plane (ESP) Block and Standard Postoperative Analgesia in Postoperative Pain and Open Abdominal Surgery, sponsored by Fatima Memorial Hospital. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Fatima Memorial Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as active, not recruiting.
  • Registered 5 months after the study started (first participant enrolled Oct 2025, registered Mar 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 137 studies in Pain, Postoperative with a site in Pakistan — 41 open to participants now, 45 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.

Enrollment
125th of 135
46 · median 78
Started
2025
with 28 others
No phase
86 of 137
27 open now
Primary completion
2026-03
later than 13 of 44 live
Registered
100th of 137
by date
Lead sponsor
6 of 137
Fatima Memorial Hospital

Among the 137 studies in Pain, Postoperative with a site in Pakistan, this one is the 125th largest by enrollment of the 135 interventional ones that give a count, is one of 29 that started in 2025, is one of 86 with no phase, reaches primary completion later than 13 of the 44 other live ones, and was the 100th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

41 of the 137 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 137 studies in Pain, Postoperative with a site in Pakistan, or all of them as a file.
02

Study summary

his randomized controlled trial aims to evaluate the efficacy of the bilateral erector spinae plane (ESP) block in reducing postoperative opioid consumption in patients undergoing open abdominal surgeries under general anesthesia

Read the detailed description

Patients undergoing abdominal surgeries experience severe postoperative pain. Conventional pain management methods, including opiates, may pose significant side effects. This study addresses the imperative need for optimizing postoperative pain management by systematically investigating the analgesic effects and complications associated with the bilateral ESP block. The study involves 46 patients allocated into two groups using a lottery method: a control group receiving standard pain control treatment, and an erector spinae block group receiving a bilateral ESP block in addition to standard pain control treatment. Pain intensity will be evaluated using a visual analogue scale (VAS) at 4, 8, 12, and 24 hours after the operation.

03

Conditions studied

  • Postoperative Pain
  • Open Abdominal Surgery

Browse trials for

Keywords

  • Erector Spinae Block
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • American Society of Anesthesiology (ASA) stage I-II.
  • Scheduled for abdominal surgery due to any indication.

Exclusion criteria

Exclusion Criteria:

  • History of Diabetes
  • History of neuropathic diseases
  • History of gastrointestinal bleeding, peptic ulcer, or inflammatory bowel disease
  • History of long-term nonsteroidal anti-inflammatory
  • History of chronic opioid analgesic use
  • History of severe hepatic or renal failure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (actual)

Study arms

  • Active comparator
    Control Group

    Patients receiving standard pain control treatment. Postoperatively, patients receive 1000 mg of IV paracetamol every 6 hours. If a patient reports a Visual Analogue Score (VAS) exceeding five, they will receive rescue analgesia consisting of nalbuphine 4mg

    Drug: Standard Postoperative Analgesia

  • Experimental
    Erector Spinae Block Group

    Patients receiving bilateral ESP block in addition to standard pain control treatment

    Procedure: Bilateral Erector Spinae Plane (ESP) Block · Drug: Standard Postoperative Analgesia

Interventions

  • ProcedureBilateral Erector Spinae Plane (ESP) Block

    Administered after the induction of general anesthesia and before the surgical incision. Local anesthetic (0.25% ropivacaine or 0.25% bupivacaine) will be injected for a total of 20-40 mL

  • DrugStandard Postoperative Analgesia

    Patients receive 1000 mg of IV paracetamol every 6 hours postoperatively. If a patient experiences a Visual Analogue Score (VAS) of more than five at any time, they receive rescue analgesia in the form of nalbuphine 4mg

06

What researchers measure

Primary outcomes

  1. Postoperative Opioid Consumption

    Assessed by the percentage of patients requiring rescue opioid analgesia. The need for rescue analgesia is determined by a Visual Analogue Score (VAS) greater than five

    Time frame: Within the first 24 hours after surgery

07

Study locations

1 site
  • Department of Anesthesia, Fatima Memorial Hospital
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Mar 2026, 5 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 5 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2026
First posted
Mar 18, 2026
StartActual
Oct 1, 2025
Primary completionEst.
Mar 31, 2026
CompletionEst.
Mar 31, 2026
Last update
Mar 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07479069
Lead sponsor
Fatima Memorial Hospital
Responsible party
Fatima Majeed (Principal Investigator, Fatima Memorial Hospital) — Principal investigator
First posted
Mar 18, 2026
Start date
Oct 1, 2025
Primary completion
Mar 31, 2026 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
Mar 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion